Stocks jump following DGDA’s vaccine approval
In the first trading session, the bank sector witnessed highest return at the Dhaka Stock Exchange
The key indices of the country's two main bourses saw a big rise in the first one-and-half hour of trading session on Tuesday following the approval of coronavirus vaccine by Directorate General of Drug Administration (DGDA).
Market analysts said, "Recently, neighbouring India has banned Covid vaccine export. However, Bangladesh government and Beximco Pharma official claimed that the decision will not effect the agreement. On Monday, DGDA has approved the vaccine to import by Beximco Pharma from India. As a result, investors feel confident to invest more in the capital market."
Market analysts further added that in the first trading session, the bank sector witnessed highest return at the Dhaka Stock Exchange (DSE).
Keep updated, follow The Business Standard's Google news channel
In this session, DSEX, the key index of the DSE rose by 139.52 points or 2.46% to 5,791.
Turnover of the DSE also rose by 23% to Tk1,232crore during the session.
Moreover, Robi, newly listed company, secured top position in turnover chart. It's 6.32 crore shares are traded worth Tk246 crore during this session.
Beximco Pharma and Beximco Limited followed Robi in turnover chart and witnessed share price hike.
The benchmark index CASPI at the Chittagong Stock Exchange (CSE) rose by 448 points to 16,821 till 11:30 am.
Moreover, DSE Shariah index DSES gained 16.83 points to 1,314 and the blue-chip index DS30 rose by 47.88 points to 2,139.
During this session, 147 companies share price rose, while 151 issues fell and 58 issues remain unchanged during the session at the DSE.
